Zentalis Pharmaceuticalsllc Stock Widgets and Gadgets
| ZNTL Stock | USD 12.71 0.17 1.32% |
| Intraday Equity Chart Quick Equity Feed Equity Search Quote Ticker Widgets Data Sheet |
Live Stock Ticker Example
- ZNTL Zentalis PharmaceuticalsLlc
- Latest Disposition of tradable shares by Vultaggio Vincent of Zentalis PharmaceuticalsL subject to Rule 16b-3
- ZNTL 12.71 -0.17
- Low 12.62
- High 13.31
- Volume 809.9 K
- Alpha -0.21
- Beta 2.79
- Return On Equity -0.67
- Return On Asset -0.29
- Current Valuation 476.93 M
- Shares Outstanding 70.96 M
- Shares Owned By Insiders 4.27 %
- Shares Owned By Institutions 95.73 %
- Number Of Shares Shorted 15.53 M
- Price To Book 2.18 X
- EBITDA (252.55 M)
- Net Income (292.19 M)
- Cash And Equivalents 455.22 M
- Cash Per Share 7.99 X
- Total Debt 45.77 M
- Debt To Equity 0.1 %
- Current Ratio 9.61 X
- Book Value Per Share 6.18 X
- Cash Flow From Operations (207.82 M)
- Short Ratio 16.26 X
- Earnings Per Share (4.47) X
- Target Price 34.4
- Number Of Employees 124
- Beta 1.73
- Market Capitalization 913.97 M
- Total Asset 562.03 M
- Retained Earnings (888.56 M)
- Working Capital 427.35 M
- Net Asset 562.03 M
- Accumulation Distribution 41986.27
- Daily Balance Of Power (0.25)
- Rate Of Daily Change 0.99
- Day Median Price 12.97
- Day Typical Price 12.88
- Price Action Indicator (0.34)
- Period Momentum Indicator (0.17)
- Relative Strength Index 43.63
Market Snapshot Widget Example
DAX Index Germany | 17,770 0.02 | |
Taiwan Weighted Taiwan | 20,213 1.56 | |
PSI 20 Stock Portugal | 6,234 0.16 | |
CROBEX Croatia | 2,813 0.65 | |
Budapest SE Hungary | 66,115 1.05 | |
IDX 30 Jakarta Indonesia | 470.93 0.54 | |
ISEQ 20 Price Ireland | 1,620 1.32 | |
NYSE Comp USA | 17,403 0.06 | |
Tel Aviv 35 Israel | 1,888 1.03 | |
Coreshares Index Tracker South Afric | 1,021 0.29 | |
IPC MEXICO Mexico | 55,416 0.68 | |
KL Technology Malaysia | 63.80 1.16 | |
IBEX 35 Index Spain | 10,634 1.02 | |
SP Merval Argentina | 1,000,000 0.00 | |
Austrian Traded Index Austria | 3,508 0.30 | |
SPASX Dividend Opportunities Australia | 1,661 0.63 | |
HNX 30 Vietnam | 496.19 0.26 | |
Bucharest BET-NG Romania | 1,201 0.59 | |
AMS Small Cap Netherlands | 1,217 1.03 | |
Oslo Exchange Mutual Norway | 1,296 0.43 | |
BEL Small Belgium | 8,960 1.74 | |
RTSI Index Russia | 1,154 0.16 | |
Basic Materials Brazil | 5,868 0.16 | |
Swiss Leader Price Switzerland | 1,839 0.20 | |
Fondo Mutuo ETF Chile | 1,415 0.56 | |
Athens General Comp Greece | 1,365 0.60 | |
Stock Exchange Of Thailand | 1,367 0.81 | |
PX Prague Stock Czech Repub | 1,547 0.68 | |
THE PHILIPPINE STOCK Philippines | 6,450 0.70 | |
WIG 30 Poland | 3,014 1.46 | |
BIST Electricity Turkey | 579.32 0.19 |
Investing Ideas
In addition to having Zentalis PharmaceuticalsL in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Compare Zentalis PharmaceuticalsL
Compare Zentalis PharmaceuticalsL To Peers
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zentalis PharmaceuticalsLlc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Complementary Tools for Zentalis Stock analysis
When running Zentalis PharmaceuticalsL's price analysis, check to measure Zentalis PharmaceuticalsL's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zentalis PharmaceuticalsL is operating at the current time. Most of Zentalis PharmaceuticalsL's value examination focuses on studying past and present price action to predict the probability of Zentalis PharmaceuticalsL's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zentalis PharmaceuticalsL's price. Additionally, you may evaluate how the addition of Zentalis PharmaceuticalsL to your portfolios can decrease your overall portfolio volatility.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |
Is Zentalis PharmaceuticalsL's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zentalis PharmaceuticalsL. If investors know Zentalis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zentalis PharmaceuticalsL listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.47) | Return On Assets (0.29) | Return On Equity (0.67) |
The market value of Zentalis PharmaceuticalsL is measured differently than its book value, which is the value of Zentalis that is recorded on the company's balance sheet. Investors also form their own opinion of Zentalis PharmaceuticalsL's value that differs from its market value or its book value, called intrinsic value, which is Zentalis PharmaceuticalsL's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zentalis PharmaceuticalsL's market value can be influenced by many factors that don't directly affect Zentalis PharmaceuticalsL's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zentalis PharmaceuticalsL's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zentalis PharmaceuticalsL is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zentalis PharmaceuticalsL's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.